Neuroprotection of Glibenclamide against Brain Injury after Cardiac Arrest via Modulation of NLRP3 Inflammasome

Glibenclamide (GBC) improves cerebral outcome after cardiac arrest (CA) in rats. We aim to investigate the effect of GBC on electrophysiological recovery and to explore the mechanism of neuroprotective effects of GBC on the acute stage of brain injury after the return of spontaneous circulation (ROSC) in a rodent model of CA. 16 anesthetized male Wistar rats subjected to 8-min asphyxia-CA were randomly assigned to the GBC or control group (N=8 each group). GBC was administered with a loading dose of 10ug/kg i. p. injection 10 min after ROSC and followed with a maintaining dose of 1.6ug/kg per 8 hours throughout the first 24 hours. Quantitative measures of EEG-information quantity (qEEG-IQ) and neurological deficit score (NDS) were used to predict and evaluate the functional outcome. There was a significant improvement of NDS in rats treated with GBC compared with the control group (p < 0.01). Compared to the control group, the rats treated with GBC showed qEEG-IQ scores that indicated better recovery (p < 0.001). Meanwhile, early QEEG-IQ was significantly correlated with 72-hr NDS as early as 45min after ROSC. Furthermore, on the molecular basis, the NLRP3 inflammasome was strongly activated in the hippocampal CA1 area 3 days after CA in control rats, which was suppressed with GBC treatment. Taken together, GBC treatment markedly improved electrophysiological and neurologic outcomes of the acute brain injury after CA. These neuroprotective effects may be associated with the attenuation of inflammatory response via down-regulation of NLRP3 inflammasome signal.

[1]  V. Dixit,et al.  Glyburide inhibits the Cryopyrin/Nalp3 inflammasome , 2009, The Journal of cell biology.

[2]  K. Kiening,et al.  Glibenclamide reduces secondary brain damage after experimental traumatic brain injury , 2014, Neuroscience.

[3]  J. Cavaillon,et al.  Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome , 2002, Circulation.

[4]  Greg Sinibaldi,et al.  Incidence of EMS-treated out-of-hospital cardiac arrest in the United States. , 2004, Resuscitation.

[5]  A. Chalkias,et al.  Post-cardiac arrest brain injury: Pathophysiology and treatment , 2012, Journal of the Neurological Sciences.

[6]  Xiaofeng Jia,et al.  Brain Monitoring in Critically Neurologically Impaired Patients , 2016, International journal of molecular sciences.

[7]  J. Simard,et al.  Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid Hemorrhage , 2009 .

[8]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[9]  Nitish V. Thakor,et al.  Quantitative EEG and neurological recovery with therapeutic hypothermia after asphyxial cardiac arrest in rats , 2006, Brain Research.

[10]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[11]  Monique L. Anderson,et al.  Regional Variation in Out-of-Hospital Cardiac Arrest Survival in the United States , 2015, Circulation.

[12]  Shengnan Wang,et al.  Glibenclamide Prevents Water Diffusion Abnormality in the Brain After Cardiac Arrest in Rats , 2018, Neurocritical Care.

[13]  X. Jia,et al.  Early Quantitative Gamma-Band EEG Marker is Associated with Outcomes After Cardiac Arrest and Targeted Temperature Management , 2015, Neurocritical Care.

[14]  Shengnan Wang,et al.  Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus , 2017, Neuropharmacology.

[15]  Nitish V. Thakor,et al.  Early electrophysiologic markers predict functional outcome associated with temperature manipulation after cardiac arrest in rats , 2008, Critical care medicine.

[16]  J. Simard,et al.  Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke , 2012, Translational Stroke Research.

[17]  J. P. de Rivero Vaccari,et al.  Activation and Regulation of Cellular Inflammasomes: Gaps in Our Knowledge for Central Nervous System Injury , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Nitish V. Thakor,et al.  Quantitative EEG and effect of hypothermia on brain recovery after cardiac arrest , 2006, IEEE Transactions on Biomedical Engineering.

[19]  S. Johann,et al.  Poststroke Inflammasome Expression and Regulation in the Peri-Infarct Area by Gonadal Steroids after Transient Focal Ischemia in the Rat Brain , 2015, Neuroendocrinology.

[20]  X. Jia,et al.  Pretreatment with low-dose fimasartan ameliorates NLRP3 inflammasome-mediated neuroinflammation and brain injury after intracerebral hemorrhage , 2018, Experimental Neurology.

[21]  Xiaofeng Jia,et al.  Quantitative EEG markers in severe post-resuscitation brain injury with therapeutic hypothermia , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[22]  Adem Can,et al.  The tail suspension test. , 2011, Journal of visualized experiments : JoVE.

[23]  Daniel D. Callow,et al.  Real-time quantitative monitoring of cerebral blood flow by laser speckle contrast imaging after cardiac arrest with targeted temperature management , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  J. Liao,et al.  NF‐κB and innate immunity in ischemic stroke , 2010, Annals of the New York Academy of Sciences.

[25]  Nitish V Thakor,et al.  Improving neurological outcomes post-cardiac arrest in a rat model: immediate hypothermia and quantitative EEG monitoring. , 2008, Resuscitation.

[26]  M. Mattson,et al.  Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke , 2013, Cell Death and Disease.